Business News›Industry›Healthcare/Biotech›Pharmaceuticals›Indian companies making Covid-19 vaccine upset over lack of norms and infrastructure
Indian companies making Covid-19 vaccine upset over lack of norms and infrastructure
Synopsis
India is staring at the risk of losing its competitive advantage in vaccine manufacturing to other countries, Biological E chairperson said, even as she also complained about lack of enough clinical trial sites and infrastructure in the country.
Hyderabad | Mumbai: One of the local companies developing a Covid-19 vaccine has aired concerns over the absence of guidelines in India for vaccine making and immunisation, as well as funding commitment from the government. India is staring at the risk of losing its competitive advantage in vaccine manufacturing to other countries, Biological E chairperson Mahima Datla said, even as she also complained about lack of enough clinical trial sites
- FONT SIZEAbcSmallAbcMediumAbcLarge
ET
Uh-oh! This is an exclusive story available for selected readers only.
Worry not. You’re just a step away.
Get Unlimited Access to The Economic Times
Why ?
Exclusive Economic Times Stories, Editorials & Expert opinion across 20+ sectors
Stock analysis. Market Research. Industry Trends on 4000+ Stocks
Clean experience with
Minimal AdsComment & Engage with ET Prime community Exclusive invites to Virtual Events with Industry Leaders A trusted team of Journalists & Analysts who can best filter signal from noise Get 1 Year Complimentary Subscription of TOI+ worth Rs.799/-
